Management of hereditary angioedema with normal C1Inh: a series of 163 French patients. [PDF]
Bocquet A +15 more
europepmc +1 more source
Population Pharmacokinetic/Pharmacodynamic Modeling of Donidalorsen, an Antisense Oligonucleotide in Development for Prophylaxis of Hereditary Angioedema. [PDF]
Diep JK +7 more
europepmc +1 more source
Vascular endothelial growth factor (VEGF) emerging as a mediator of hereditary angioedema (HAE). [PDF]
Giavina-Bianchi P, Aun MV, Kalil J.
europepmc +1 more source
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers. [PDF]
Levy DS +4 more
europepmc +1 more source
Eosinophilic inflammation in hereditary angioedema: a single-center real-world retrospective chart review study. [PDF]
Boch K +3 more
europepmc +1 more source
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee. [PDF]
Cancian M +10 more
europepmc +1 more source
Patient Preferences for Long-Term Prophylactic Treatment in Hereditary Angioedema: A Discrete-Choice Experiment. [PDF]
Villa KF +6 more
europepmc +1 more source
Behavioural withdrawal during an acute stress test as a marker of psychobiological vulnerability in hereditary angioedema. [PDF]
Ranucci L +8 more
europepmc +1 more source
Disease control and disease activity in hereditary angioedema: two sides of the same coin? [PDF]
Heibati B, Borle J, Ritchie B, Adatia A.
europepmc +1 more source
Exposure-Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema. [PDF]
Singh P +7 more
europepmc +1 more source

